If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 141 - 150 of 265
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Objective
The purpose of this part of this study is to compare the effects, good and/or bad, of the standard treatment (radiation therapy and cisplatin) with one of the experimental treatments chosen from the first part of the study (either radiation therapy and docetaxel or radiation therapy, cetuximab, and docetaxel) to find out which is better.
Protocol No
RTOG-1216
Categories
A Phase III Trial of One Vs. Two Years of Maintenance Olaparib, with or without Bevacizumab, in Patients with BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy
Objective
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer.
Protocol No
NRG-GY036
Categories
CureAA: Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia - A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, o
Objective
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Protocol No
HEMONC-CTN-2207-CUREAA
Categories
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Post-Approval Study
Objective
GORE TAMBE Post-Approval Study
Protocol No
SURG-WLGORE-TAMBE
Categories
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of IMPT-314, a CD19/20 Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy in Participants with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Objective
The purpose of this research is to find new ways to treat lymphomas that have either come back after treatment or have stopped responding to treatment.
Protocol No
IMMPACT-MPCT-012L
Categories
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Objective
PLDR CRT for esophageal cancer
Protocol No
IIT-PUCKETT-PULSO
Categories
ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects with Leiomyosarcoma (ARGSARC): A Randomized, Double Blind, Multi-Center Phase 3 Trial
Objective
A Randomized Phase 3 Trial of ADI-PEG20 in Patients with Leiomeyosarcoma
Protocol No
POLARIS-2022-001-ARGSARC
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-Cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-Cancer Agents in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Objective
Study of loncastuximab tesirine in R/R B-cell Non-Hodgkin lymphoma patients
Protocol No
ADCT-402-105-LOTIS-7
Categories
Concept Identification for MEG Aphasia
Objective
Concept Identification for MEG Aphasia
Protocol No
ANES-IIT-GROSS-CONCEPT-ID
Categories
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Objective
Clinical trial of atrial fibrillation patients comparing left atrial appendage occlusion therapy to non-vitamin K antagonist oral anticoagulants
Protocol No
CVC-ABBOTT-CATALYST
Categories